Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$8.45 - $12.48 $56,800 - $83,890
6,722 Added 38.95%
23,981 $242,000
Q1 2023

May 08, 2023

BUY
$9.21 - $14.98 $11,328 - $18,425
1,230 Added 7.67%
17,259 $176,000
Q4 2022

Feb 07, 2023

BUY
$8.57 - $17.0 $137,368 - $272,493
16,029 New
16,029 $150,000
Q2 2022

Aug 04, 2022

SELL
$10.55 - $18.81 $98,790 - $176,136
-9,364 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$11.67 - $26.72 $12,708 - $29,098
1,089 Added 13.16%
9,364 $160,000
Q4 2021

Feb 07, 2022

BUY
$13.77 - $42.56 $113,946 - $352,184
8,275 New
8,275 $221,000

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.